Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · IEX Real-Time Price · USD

9.34

-0.23 (-2.40%)

At close: Apr 19, 2024, 4:00 PM

9.37

+0.03 (0.32%)

After-hours: Apr 19, 2024, 4:03 PM EDT

Fennec Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2002
Net Income	-16.05	-23.71	-17.35	-18.11	-12.78	-9.89	-7.05	-2.79	-0.66	-2.18	Upgrade
Share-Based Compensation	5.35	4.22	4.02	2.88	3.08	2.1	2.26	0.7	0.1	1.06	Upgrade
Other Operating Activities	-6.45	1.44	-0.89	-0.36	0.63	-0.04	1.15	-0.04	-1.3	-0.58	Upgrade
Operating Cash Flow	-17.14	-18.06	-14.22	-15.6	-9.06	-7.83	-3.64	-2.12	-1.86	-1.7	Upgrade
Share Issuance / Repurchase	0	0	0	31.97	0	0	27.38	5	0	2.18	Upgrade
Debt Issued / Paid	5	19.94	5	0	0	0	0	0	0	0	Upgrade
Other Financing Activities	1.64	0.8	-0.02	0.32	-0.07	2.35	0.59	0.11	0.5	0.16	Upgrade
Financing Cash Flow	6.64	20.73	4.98	32.29	-0.07	2.35	27.98	5.11	0.5	2.34	Upgrade
Net Cash Flow	-10.51	2.67	-9.24	16.69	-9.13	-5.48	24.33	2.98	-1.37	0.64	Upgrade
Free Cash Flow	-17.14	-18.06	-14.22	-15.6	-9.06	-7.83	-3.64	-2.12	-1.86	-1.7	Upgrade
Free Cash Flow Margin	-80.67%	-1176.42%	-	-9173.53%	-	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-0.65	-0.69	-0.55	-0.66	-0.46	-0.41	-0.24	-0.17	-0.17	-0.17	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).